MedPath

Study on the effect and mechanism of Erzhitiangui granule in improving the pregnancy outcome of advanced age patients with IVF infertility

Not Applicable
Conditions
infertile women of advanced reproductive age
Registration Number
ITMCTR2200006728
Lead Sponsor
Reproductive Hospital Affiliated to Shandong University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

? Age 35-42 years old; FSH <12mIU/ml, the number of antral follicles > 5; ? Patients with tubal factors to undergo IVF; ? Normal liver and kidney function, no gynecological and other systemic diseases.

Exclusion Criteria

?Uterine malformation,including single horn uterus, uterine cavity adhesion;?Severe diseases, including diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, and mental illness; ?Received hormone drug therapy within last six month; ? Allergic to the drug used in this study; ?Taken other traditional Chinese medicine treating infertility in the past three month.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pregnancy outcome;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath